查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004515

切片检查活检市场报告：趋势、预测和竞争分析（至2035年）

Biopsy Gun Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球切片检查市场前景广阔，医院和诊所预计将迎来大量机会。预计2026年至2035年，全球切片检查市场将以7.9%的复合年增长率成长，到2035年市场规模预计将达到12.85亿美元。推动该市场成长的关键因素包括：对微创诊断的需求不断增长、癌症和肿瘤发病率上升，以及医院和诊所对活检技术的日益普及。

  • 根据 Lucintel 的预测，全自动化产品在预测期内有望呈现更高的成长率。
  • 从应用领域来看，医院产业预计将呈现最高的成长率。
  • 从区域来看，亚太地区预计在预测期内将呈现最高的成长率。

切片检查市场的新趋势

受技术进步、微创手术需求成长以及对提高诊断准确性的重视等因素驱动，切片检查市场正在快速发展。随着医疗服务提供者寻求更有效率、更安全、更人性化的方案，市场上涌现许多创新产品和技术。这些进步不仅改善了临床疗效，也拓展了切片检查手术在各医学专科的应用范围。以下关键趋势突显了正在塑造该市场的变革性变化，反映了精准医疗、技术整合和以患者为中心的医疗模式的转变。

  • 技术创新与智慧切片检查设备：机器人辅助成像、即时影像处理和自动化等先进技术的融合正在革新切片检查。这些智慧型设备能够提高活检的准确性、缩短手术时间并增强安全性。诸如电动可程式设计切片检查等创新技术使临床医生能够获得更精确的组织样本，尤其是在解剖结构复杂的部位。推动这些设备应用的动力源自于对微创、高效和可靠的切片检查技术的需求，最终将带来更好的诊断效果和更高的患者满意度。
  • 微创技术的广泛应用：随着患者寻求疼痛更少、恢復更快的治疗方案，微创切片检查技术正成为主流。专为这些手术设计的切片检查设备也日趋精密，采用更细的针头，操作也更方便。这一趋势在肿瘤学领域尤其显着，因为早期发现至关重要。微创技术的引入减少了併发症、缩短了住院时间，并降低了整体医疗成本，使其成为医护人员和病患的首选。
  • 肿瘤学和介入放射学领域的应用不断拓展：切片检查的需求已从传统的乳房和皮肤切片检查等应用扩展到复杂的肿瘤学和介入放射学手术。先进的切片检查现在可以靶向位于组织深处的肿瘤，并获取高品质的组织样本进行分子分析。这种应用拓展是由癌症发生率的上升以及对精准诊断和个人化治疗方案的需求所驱动的。因此，製造商正在开发针对特定临床应用的专用切片检查，从而扩大了市场范围。
  • 安全性和无菌性日益受到重视：确保病患安全和在切片检查过程中保持无菌是首要任务。市场上正在研发一次性切片检查，以降低交叉感染的风险。此外，符合人体工学的设计、安全锁和易于清洁的组件等功能也逐渐成为标准配备。这些创新有助于最大限度地降低感染风险，提高手术安全性，并符合严格的医疗法规。这种对安全的重视对于赢得临床医生的信任以及在各种医疗机构中推广使用切片检查至关重要。
  • 携带式手持设备需求激增：携带式手持切片检查市场需求激增，这类设备柔软性易用，适用于包括门诊和偏远地区在内的各种临床环境。这些设备轻巧便携，采用电池供电，设计便于快速设置，是床边诊断的理想选择。其便携性提高了医疗资源匮乏地区进行切片检查的便利性，并能实现快速诊断，尤其是在紧急情况下。这一趋势与医疗保健分散化的大趋势相符，有助于改善患者就医途径，并减轻大规模医疗机构的负担。

这些趋势正在重塑整个切片检查市场，促进创新，拓展临床应用，并优先考虑安全性和便利性。这推动了更精准、更人性化、更通用的切片检查解决方案的普及，最终将提升全球医疗系统的诊断准确性和患者疗效。

切片检查市场的最新趋势

受技术创新、微创手术需求成长以及医疗保健领域应用范围不断扩大的推动，切片检查市场正经历快速成长。这些进步正在提升诊断准确性、患者舒适度和手术效率。随着医疗机构寻求更有效的工具，以及投资增加和监管核准的推进，该市场有望实现显着成长。对于希望掌握新兴趋势并改善患者预后的利害关係人相关人员，了解这些关键机会至关重要。

  • 切片检查的技术创新：更高的精准度和安全性正在革新切片检查流程。新型号融合了与先进成像技术的兼容性、自动化功能和符合人体工学的设计，从而缩短了手术时间并提高了检体品质。这些创新增强了临床医生的信心，拓展了在复杂病例中的应用，并吸引了投资。因此，市场对高科技切片检查的需求激增，推动了竞争性成长，并刺激了持续的研发活动。
  • 微创手术的广泛应用：向微创诊断的转变正在推动切片检查的销售。由于患者倾向于选择疼痛更少、恢復更快的治疗方案，医疗机构也越来越多地采用先进的切片检查工具。这一趋势在肿瘤科、乳房科和肝病科的诊断中尤其明显。微创手术的普及提高了诊断准确性，减少了併发症，并缩短了住院时间。因此，市场受益于手术数量的增加和应用范围的扩大，从而推动了整个行业的成长。
  • 肿瘤学及其他领域的应用拓展：癌症切片检查的应用范围正日益扩展，超越了其传统范畴，尤其是在肿瘤学、循环系统和肌肉骨骼诊断领域。这种应用范围的扩大使得癌症的早期发现和个人化治疗方案的发展成为可能。这种多样化的应用推动了对不同组织和成像技术而设计的专用切片检查设备的需求。随着临床证据证实其有效性，市场正透过新产品的推出和该技术在多个医学领域的日益普及而不断增长。
  • 监管核准与市场拓展：监管机构正在核准安全性和有效性均有所提升的创新切片检查。这些核准有助于产品进入市场，并增强临床医生的信心。此外，由于医疗基础设施的改善和公众意识的提高，新兴市场对活检枪的接受度也不断提高。战略合作与投资进一步加速了市场扩张。这种法规环境正在促进创新，扩大地域覆盖范围，增强竞争格局，并最终推动产业的永续发展。
  • 数位技术和数据整合的影响：人工智慧和数据分析等数位技术的整合正在提升切片检查的功能。即时影像导引、自动化检体分析和资料管理提高了手术的准确性和工作流程的效率。这些进步使得个人化诊断和更佳的患者管理成为可能。智慧切片检查设备的日益普及正在推动市场创新并创造新的收入来源，市场也因此受益。数位整合将重新定义行业标准并拓展切片检查手术的范围。

近年来，切片检查市场的发展正透过提高诊断准确性、拓展应用领域和加速技术创新，显着改变产业格局。这些机会正在推动市场成长、吸引投资并改善患者照护。因此，该行业呈现出持续扩张的迹象，不断增强的竞争力和持续进步正在塑造其未来的发展轨迹。

目录

第一章执行摘要

第二章 市场概览

  • 背景与分类
  • 供应链

第三章 市场趋势与预测分析

  • 宏观经济趋势与预测
  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

第四章 全球癌症切片检查市场：按类型划分

  • 吸引力分析：按类型
  • 全自动
  • 半自动

第五章：全球癌症切片检查市场：按应用领域划分

  • 吸引力分析：依目的
  • 医院
  • 诊所
  • 其他的

第六章 区域分析

第七章：北美切片检查切片市场

  • 北美切片检查市场：按类型划分
  • 北美切片检查市场：按应用领域划分
  • 美国切片检查市场
  • 加拿大切片检查市场
  • 墨西哥切片检查市场

第八章：欧洲切片检查市场

  • 欧洲癌症切片检查市场：按类型划分
  • 欧洲癌症切片检查市场：按应用领域划分
  • 德国切片检查市场
  • 法国切片检查市场
  • 义大利切片检查市场
  • 西班牙切片检查市场
  • 英国切片检查市场

第九章：亚太地区癌症切片检查市场

  • 亚太地区癌症切片检查市场：按类型划分
  • 亚太地区癌症切片检查市场：按应用领域划分
  • 中国切片检查市场
  • 印度切片检查市场
  • 日本癌症切片检查样本市场
  • 韩国切片检查市场
  • 印尼切片检查市场

第十章：世界各地的切片检查枪市场

  • 其他地区切片检查枪市场：按类型划分
  • 其他地区切片检查枪市场：按应用领域划分
  • 中东切片检查市场
  • 南非癌症切片检查市场
  • 非洲切片检查市场

第十一章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析
  • 市占率分析

第十二章 机会与策略分析

  • 价值链分析
  • 成长机会分析
  • 新趋势：全球癌症切片检查市场
  • 战略分析

第十三章：价值链中主要企业的公司概况

  • 竞争分析概述
  • Roussel Delma Pharmaceuticals
  • Advin Health Care
  • Biomedical
  • Cathwide Medical
  • HEGA-Medical
  • Histo
  • Medax
  • Moeller Medical
  • Prosimed
  • Slaughter Supply

第十四章附录

The future of the global biopsy gun market looks promising with opportunities in the hospital and clinic markets. The global biopsy gun market is expected to reach an estimated $1,285 million by 2035 with a CAGR of 7.9% from 2026 to 2035. The major drivers for this market are the increasing demand for minimally invasive diagnostics, the rising prevalence of cancer & tumors, and the growing adoption in hospitals & clinics.

  • Lucintel forecasts that, within the type category, fully automatic is expected to witness higher growth over the forecast period.
  • Within the application category, hospital is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Biopsy Gun Market

The biopsy gun market is experiencing rapid evolution driven by technological advancements, increasing demand for minimally invasive procedures, and a focus on improving diagnostic accuracy. As healthcare providers seek more efficient, safe, and patient-friendly options, the market is witnessing the emergence of innovative products and practices. These developments are not only enhancing clinical outcomes but also expanding the scope of biopsy procedures across various medical specialties. The following key trends highlight the transformative changes shaping this market, reflecting a shift towards precision medicine, technological integration, and patient-centric care.

  • Technological Innovation and Smart Biopsy Devices: The integration of advanced technologies such as robotic assistance, real-time imaging, and automation is revolutionizing biopsy guns. These smart devices offer enhanced precision, reduced procedure time, and improved safety profiles. Innovations like motorized and programmable biopsy guns enable clinicians to perform more accurate tissue sampling, especially in challenging anatomical locations. The adoption of these devices is driven by the need for minimally invasive, efficient, and reliable biopsy procedures, ultimately leading to better diagnostic outcomes and patient satisfaction.
  • Growing Adoption of Minimally Invasive Procedures: There is a significant shift towards minimally invasive biopsy techniques, driven by patient preference for less painful and quicker recovery options. Biopsy guns designed for such procedures are becoming more sophisticated, offering features like smaller gauge needles and enhanced maneuverability. This trend is particularly prominent in oncology, where early detection is critical. The adoption of minimally invasive methods reduces complications, hospital stays, and overall healthcare costs, making them a preferred choice among healthcare providers and patients alike.
  • Expansion in Oncology and Interventional Radiology Applications: The demand for biopsy guns is expanding beyond traditional use in breast and skin biopsies to include complex oncological and interventional radiology procedures. Advanced biopsy guns are now capable of targeting deep-seated tumors and providing high-quality tissue samples for molecular analysis. This expansion is driven by the rising prevalence of cancer and the need for precise diagnosis and personalized treatment plans. As a result, manufacturers are developing specialized biopsy guns tailored for specific clinical applications, broadening the market scope.
  • Increasing Focus on Safety and Sterility: Ensuring patient safety and maintaining sterility during biopsy procedures are paramount. The market is witnessing the development of disposable, single-use biopsy guns that reduce cross-contamination risks. Additionally, features like ergonomic designs, safety locks, and easy-to-clean components are becoming standard. These innovations help minimize infection risks, improve procedural safety, and comply with stringent healthcare regulations. The emphasis on safety is crucial in gaining clinician confidence and expanding the adoption of biopsy guns across diverse healthcare settings.
  • Rising Demand for Portable and Handheld Devices: The market is witnessing a surge in portable, handheld biopsy guns that offer flexibility and ease of use in various clinical environments, including outpatient clinics and remote locations. These devices are lightweight, battery-operated, and designed for quick setup, making them ideal for point-of-care diagnostics. The portability enhances access to biopsy procedures in underserved areas and facilitates rapid diagnosis, especially in emergency settings. This trend aligns with the broader shift towards decentralized healthcare, improving patient access and reducing the burden on large medical facilities.

These trends are collectively reshaping the biopsy gun market by fostering innovation, expanding clinical applications, and emphasizing safety and convenience. They are driving the adoption of more precise, patient-friendly, and versatile biopsy solutions, ultimately improving diagnostic accuracy and patient outcomes across healthcare systems worldwide.

Recent Developments in the Biopsy Gun Market

The biopsy gun market is experiencing rapid advancements driven by technological innovations, increasing demand for minimally invasive procedures, and expanding applications across medical fields. These developments are transforming diagnostic accuracy, patient comfort, and procedural efficiency. As healthcare providers seek more effective tools, the market is poised for significant growth, supported by rising investments and regulatory approvals. Understanding these key opportunities is essential for stakeholders aiming to capitalize on emerging trends and improve patient outcomes.

  • Technological Innovations in Biopsy Guns: Enhanced precision and safety features are revolutionizing biopsy procedures. New models incorporate advanced imaging compatibility, automated functions, and ergonomic designs, reducing procedure time and improving sample quality. These innovations increase clinician confidence, expand usage in complex cases, and attract investments. As a result, the market is witnessing a surge in demand for high-tech biopsy guns, fostering competitive growth and encouraging ongoing R&D efforts.
  • Rising Adoption of Minimally Invasive Procedures: The shift towards minimally invasive diagnostics is boosting biopsy gun sales. Patients prefer less painful, quicker recovery options, prompting healthcare providers to adopt advanced biopsy tools. This trend is especially prominent in oncology, breast, and liver diagnostics. The increased adoption enhances diagnostic accuracy, reduces complications, and shortens hospital stays. Consequently, the market benefits from higher procedural volumes and broader application scopes, fueling overall industry expansion.
  • Growing Applications in Oncology and Other Fields: Biopsy guns are increasingly used beyond traditional applications, notably in oncology, cardiology, and musculoskeletal diagnostics. The expanding scope allows for early detection and personalized treatment planning. This diversification drives demand for specialized biopsy devices tailored to different tissues and imaging techniques. As clinical evidence supports their efficacy, the market experiences growth through new product launches and increased procedural adoption across multiple medical disciplines.
  • Regulatory Approvals and Market Expansion: Regulatory bodies are approving innovative biopsy guns with improved safety and efficacy profiles. These approvals facilitate market entry and boost clinician confidence. Additionally, emerging markets are witnessing increased adoption due to rising healthcare infrastructure and awareness. Strategic collaborations and investments are further accelerating market expansion. This regulatory environment fosters innovation, broadens geographic reach, and enhances competitive dynamics, ultimately contributing to sustained industry growth.
  • Impact of Digital and Data Integration: Integration of digital technologies, such as AI and data analytics, is enhancing biopsy gun functionality. Real-time imaging guidance, automated sample analysis, and data management improve procedural accuracy and workflow efficiency. These advancements enable personalized diagnostics and better patient management. The market benefits from increased adoption of smart biopsy devices, fostering innovation and creating new revenue streams. Digital integration is set to redefine industry standards and expand the scope of biopsy procedures.

The recent developments in the biopsy gun market are significantly transforming the industry landscape by improving diagnostic precision, expanding application areas, and fostering technological innovation. These opportunities are driving market growth, attracting investments, and enhancing patient care. As a result, the industry is poised for sustained expansion, with increased competitiveness and ongoing advancements shaping its future trajectory.

Strategic Growth Opportunities in the Biopsy Gun Market

The biopsy gun market is experiencing significant growth driven by advancements in medical technology, the increasing prevalence of cancer, and the demand for minimally invasive diagnostic procedures. Rising awareness about early detection and improved healthcare infrastructure further contributes to expanding opportunities. Manufacturers are focusing on innovation, safety, and precision to meet the evolving needs of healthcare providers and patients. This dynamic environment presents numerous avenues for strategic expansion and technological development, promising substantial market growth in the coming years.

  • Increasing Adoption of Minimally Invasive Procedures: The rising preference for minimally invasive biopsy techniques is a key growth driver. Biopsy guns offer precise, less painful, and quicker procedures, reducing patient recovery time. As healthcare providers aim to improve patient outcomes and reduce hospital stays, demand for advanced biopsy guns is surging. Technological innovations that enhance accuracy and safety are further fueling adoption across hospitals, clinics, and specialized diagnostic centers worldwide.
  • Rising Incidence of Cancer and Chronic Diseases: The growing prevalence of cancer and other chronic diseases globally is significantly boosting the need for early diagnosis. Biopsy guns are essential tools for obtaining tissue samples for accurate diagnosis and treatment planning. Increased screening programs and awareness campaigns are leading to higher detection rates, thereby expanding the market. This trend underscores the importance of reliable biopsy devices to support timely and effective medical interventions.
  • Technological Innovations in Biopsy Devices: Continuous advancements in biopsy gun technology, such as automation, improved ergonomics, and enhanced imaging compatibility, are creating new growth opportunities. These innovations increase procedural precision, reduce complications, and improve patient comfort. Companies investing in R&D to develop smarter, more efficient devices are gaining competitive advantages. The integration of digital and imaging technologies is expected to further revolutionize biopsy procedures, expanding market reach and application scope.
  • Growing Healthcare Infrastructure in Emerging Markets: Emerging economies are witnessing rapid healthcare infrastructure development, increasing access to diagnostic services. This expansion creates a substantial market for biopsy guns, especially in rural and underserved areas. Government initiatives, investments, and partnerships are facilitating the adoption of advanced medical devices. As healthcare systems strengthen, demand for reliable, cost-effective biopsy solutions is expected to rise, opening new avenues for market players to expand their presence.
  • Increasing Focus on Safety and Sterility Standards: The emphasis on patient safety and infection control is prompting manufacturers to develop biopsy guns with enhanced safety features. Innovations such as disposable components, safety locks, and sterilization compatibility are gaining importance. Regulatory standards are becoming more stringent, encouraging product improvements. This focus on safety not only reduces procedural risks but also boosts clinician confidence, thereby driving market growth through increased adoption of safer, compliant biopsy devices.

The overall impact of these opportunities is set to significantly accelerate market growth, fostering innovation and expanding access to advanced diagnostic tools. As technological, infrastructural, and safety considerations evolve, the biopsy gun market is poised for sustained expansion, ultimately improving diagnostic accuracy and patient outcomes worldwide.

Biopsy Gun Market Driver and Challenges

The biopsy gun market is influenced by a variety of technological, economic, and regulatory factors that shape its growth and development. Advances in medical technology, increasing demand for minimally invasive procedures, and evolving regulatory standards are key drivers. Economic factors such as rising healthcare expenditure and the growing prevalence of chronic diseases further propel market expansion. However, the market also faces challenges, including high costs, regulatory hurdles, and concerns over procedural safety. Understanding these drivers and challenges is essential for stakeholders to navigate the dynamic landscape effectively and capitalize on emerging opportunities.

The factors responsible for driving the biopsy gun market include:-

  • Technological Innovation: The continuous development of advanced biopsy guns with improved precision, safety features, and ease of use significantly enhances clinical outcomes. Innovations such as automated and imaging-guided biopsy guns enable more accurate tissue sampling, reducing procedure time and patient discomfort. These technological advancements attract healthcare providers seeking efficient diagnostic tools, thereby expanding market adoption. Moreover, integration with digital health systems and AI-driven guidance further boosts the market by offering enhanced diagnostic accuracy and workflow efficiency, making biopsy procedures more reliable and accessible.
  • Rising Prevalence of Chronic Diseases: The increasing incidence of cancer, infectious diseases, and other chronic conditions worldwide is a major driver. As these diseases often require tissue diagnosis for effective treatment planning, the demand for biopsy procedures rises. The growing aging population, which is more susceptible to such diseases, further amplifies this need. Consequently, healthcare providers are investing in advanced biopsy guns to meet the rising diagnostic demand, fueling market growth. This trend is particularly prominent in developing regions where healthcare infrastructure is expanding rapidly to accommodate the increasing disease burden.
  • Growing Preference for Minimally Invasive Procedures: Patients and clinicians favor minimally invasive diagnostic options due to reduced pain, shorter recovery times, and lower complication rates. Biopsy guns facilitate such procedures, making them a preferred choice over traditional surgical biopsies. The shift towards outpatient and office-based procedures also drives demand for portable, easy-to-use biopsy devices. This preference encourages manufacturers to innovate and improve biopsy gun designs, thereby expanding their market share. Additionally, insurance providers are more likely to cover minimally invasive procedures, further incentivizing their adoption and supporting market growth.
  • Increasing Healthcare Expenditure and Investment: Rising healthcare budgets and investments in diagnostic infrastructure are fueling the market. Governments and private entities are allocating funds to improve diagnostic capabilities, including the procurement of advanced biopsy guns. This financial support enables healthcare facilities to upgrade their equipment, adopt new technologies, and expand diagnostic services. The increasing affordability of high-quality biopsy devices due to technological advancements also makes them accessible to a broader range of healthcare providers, especially in emerging markets, thus broadening the market scope.
  • Expansion of Diagnostic and Interventional Procedures: The expanding scope of diagnostic and interventional radiology procedures is a significant driver. Biopsy guns are integral to various minimally invasive interventions, including tumor biopsies, lymph node sampling, and organ-specific tissue collection. As medical practitioners increasingly adopt these procedures for early diagnosis and treatment monitoring, the demand for reliable biopsy guns grows. The development of specialized biopsy devices tailored for different anatomical sites and clinical needs further stimulates market expansion, supporting better patient outcomes and procedural efficiency.

The challenges facing the biopsy gun market include:-

  • High Cost of Advanced Biopsy Guns: Despite technological advancements, the high cost of sophisticated biopsy guns remains a barrier, especially in developing regions. These devices often require significant investment, which can limit adoption among smaller healthcare providers and in resource-constrained settings. Additionally, the cost of maintenance, disposables, and training adds to the overall expenditure, impacting the affordability and widespread use of these devices. This financial barrier can slow market growth and restrict access to cutting-edge diagnostic tools, thereby affecting overall market penetration.
  • Regulatory and Approval Hurdles: Stringent regulatory standards and lengthy approval processes pose significant challenges. Biopsy guns must meet rigorous safety, efficacy, and quality standards set by health authorities such as the FDA or EMA. Navigating these regulatory pathways can delay product launches and increase costs for manufacturers. Moreover, evolving regulations and compliance requirements necessitate continuous updates and testing, which can hinder innovation and market entry, especially for smaller or emerging companies. These hurdles can slow down the availability of new and improved biopsy devices in the market.
  • Safety and Procedural Risks: Concerns over procedural safety, including risks of infection, bleeding, and tissue damage, impact market growth. Ensuring patient safety requires rigorous training and adherence to protocols, which can be challenging in busy clinical settings. Additionally, complications arising from improper use or device malfunction can lead to legal liabilities and reputational damage for manufacturers. Addressing these safety concerns involves ongoing research, improved device design, and comprehensive training programs, which can increase costs and complexity for providers and manufacturers alike.

The biopsy gun market is driven by technological innovations, rising disease prevalence, and a shift towards minimally invasive procedures, all supported by increasing healthcare investments. However, high costs, regulatory challenges, and safety concerns pose significant hurdles. These factors collectively influence market dynamics, with opportunities for growth in emerging regions and specialized applications. Navigating these drivers and challenges will be crucial for stakeholders aiming to expand their market presence and improve diagnostic outcomes. Overall, the markets future depends on balancing innovation with safety, affordability, and regulatory compliance to meet the evolving needs of healthcare providers and patients worldwide.

List of Biopsy Gun Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopsy gun companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopsy gun companies profiled in this report include-

  • Roussel Delma Pharmaceuticals
  • Advin Health Care
  • Biomedical
  • Cathwide Medical
  • HEGA-Medical
  • Histo
  • Medax
  • Moeller Medical
  • Prosimed
  • Slaughter Supply

Biopsy Gun Market by Segment

The study includes a forecast for the global biopsy gun market by type, application, and region.

Biopsy Gun Market by Type [Value from 2019 to 2035]:

  • Fully Automatic
  • Semi-Automatic

Biopsy Gun Market by Application [Value from 2019 to 2035]:

  • Hospitals
  • Clinics
  • Others

Biopsy Gun Market by Region [Value from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Biopsy Gun Market

The biopsy gun market has experienced significant advancements driven by technological innovations, increasing demand for minimally invasive procedures, and expanding healthcare infrastructure worldwide. Countries are adopting new devices that improve accuracy, safety, and patient comfort. Regulatory approvals and rising investments in medical research further propel market growth. The evolving landscape reflects a focus on precision medicine and personalized treatment options, with key players continuously innovating to meet the needs of diverse healthcare settings. These developments are shaping the future of diagnostic and therapeutic procedures, making biopsy guns more efficient, user-friendly, and accessible across different regions.

  • United States: The US market has seen rapid adoption of advanced biopsy guns with enhanced imaging compatibility and ergonomic designs. Innovations include automated and semi-automated devices that improve precision and reduce procedure time. Regulatory approvals for new products have increased, supported by strong healthcare infrastructure and high healthcare expenditure. The rise in minimally invasive procedures and growing awareness about early diagnosis have further fueled market growth. Additionally, collaborations between medical device companies and research institutions are fostering innovation, leading to the development of smarter, more efficient biopsy guns tailored for various clinical applications.
  • China: China's biopsy gun market is expanding due to increasing healthcare investments and a rising prevalence of chronic diseases requiring early diagnosis. Local manufacturers are gaining prominence by offering cost-effective, technologically advanced devices that meet domestic demand. The government's focus on healthcare reform and infrastructure development has improved access to diagnostic procedures. Moreover, the adoption of minimally invasive techniques is growing, supported by rising awareness among healthcare professionals. International companies are entering the Chinese market through partnerships and joint ventures, boosting innovation and product availability. The market is expected to continue its rapid growth trajectory driven by technological adoption and expanding healthcare coverage.
  • Germany: Germany's market is characterized by high-quality, precision biopsy guns used predominantly in specialized medical centers. The focus on patient safety and comfort has led to innovations in device design, including improved needle stability and imaging integration. Stringent regulatory standards ensure high product quality and safety. The increasing prevalence of cancer and other chronic diseases has driven demand for accurate biopsy tools. Germany's strong healthcare system and emphasis on research and development foster continuous innovation. Additionally, collaborations between academia and industry are leading to the development of advanced biopsy devices that cater to complex diagnostic needs, maintaining Germany's position as a leader in medical technology.
  • India: The Indian biopsy gun market is witnessing rapid growth due to rising healthcare awareness, increasing prevalence of cancer, and expanding healthcare infrastructure. Cost-effective, portable, and easy-to-use devices are in high demand, especially in rural and semi-urban areas. Government initiatives to improve healthcare access and the growth of private healthcare providers are further boosting market expansion. Local manufacturers are innovating to produce affordable devices that meet international standards. The adoption of minimally invasive procedures is increasing, supported by a growing number of trained healthcare professionals. Overall, the market is poised for significant growth driven by technological adoption and increasing healthcare expenditure.
  • Japan: Japan's market is characterized by high adoption of advanced biopsy guns with integrated imaging capabilities and enhanced safety features. The focus on precision medicine and early diagnosis has led to innovations in device technology. The aging population has increased the demand for minimally invasive and outpatient procedures, prompting manufacturers to develop user-friendly and efficient devices. Strict regulatory standards ensure high product safety and quality. Japan's strong healthcare infrastructure and emphasis on research and development foster continuous innovation. Collaborations between industry and academia are advancing the development of sophisticated biopsy tools, maintaining Japan's leadership in medical technology and innovation.

Features of the Global Biopsy Gun Market

  • Market Size Estimates: Biopsy gun market size estimation in terms of value ($M).
  • Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
  • Segmentation Analysis: Biopsy gun market size by type, application, and region in terms of value ($M).
  • Regional Analysis: Biopsy gun market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the biopsy gun market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopsy gun market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biopsy gun market by type (fully automatic and semi-automatic), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Biopsy Gun Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Fully Automatic : Trends and Forecast (2019-2035)
  • 4.4 Semi-Automatic : Trends and Forecast (2019-2035)

5. Global Biopsy Gun Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospitals : Trends and Forecast (2019-2035)
  • 5.4 Clinics : Trends and Forecast (2019-2035)
  • 5.5 Others : Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Biopsy Gun Market by Region

7. North American Biopsy Gun Market

  • 7.1 Overview
  • 7.2 North American Biopsy Gun Market by Type
  • 7.3 North American Biopsy Gun Market by Application
  • 7.4 The United States Biopsy Gun Market
  • 7.5 Canadian Biopsy Gun Market
  • 7.6 Mexican Biopsy Gun Market

8. European Biopsy Gun Market

  • 8.1 Overview
  • 8.2 European Biopsy Gun Market by Type
  • 8.3 European Biopsy Gun Market by Application
  • 8.4 German Biopsy Gun Market
  • 8.5 French Biopsy Gun Market
  • 8.6 Italian Biopsy Gun Market
  • 8.7 Spanish Biopsy Gun Market
  • 8.8 The United Kingdom Biopsy Gun Market

9. APAC Biopsy Gun Market

  • 9.1 Overview
  • 9.2 APAC Biopsy Gun Market by Type
  • 9.3 APAC Biopsy Gun Market by Application
  • 9.4 Chinese Biopsy Gun Market
  • 9.5 Indian Biopsy Gun Market
  • 9.6 Japanese Biopsy Gun Market
  • 9.7 South Korean Biopsy Gun Market
  • 9.8 Indonesian Biopsy Gun Market

10. ROW Biopsy Gun Market

  • 10.1 Overview
  • 10.2 ROW Biopsy Gun Market by Type
  • 10.3 ROW Biopsy Gun Market by Application
  • 10.4 Middle Eastern Biopsy Gun Market
  • 10.5 South American Biopsy Gun Market
  • 10.6 African Biopsy Gun Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global Biopsy Gun Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 Roussel Delma Pharmaceuticals
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Advin Health Care
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Biomedical
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Cathwide Medical
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 HEGA-Medical
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Histo
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Medax
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Moeller Medical
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Prosimed
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Slaughter Supply
    • Company Overview
    • Biopsy Gun Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Biopsy Gun Market
  • Figure 2.1: Usage of Biopsy Gun Market
  • Figure 2.2: Classification of the Global Biopsy Gun Market
  • Figure 2.3: Supply Chain of the Global Biopsy Gun Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Biopsy Gun Market
  • Figure 4.1: Global Biopsy Gun Market by Type in 2019, 2025, and 2035
  • Figure 4.2: Trends of the Global Biopsy Gun Market ($M) by Type
  • Figure 4.3: Forecast for the Global Biopsy Gun Market ($M) by Type
  • Figure 4.4: Trends and Forecast for Fully Automatic in the Global Biopsy Gun Market (2019-2035)
  • Figure 4.5: Trends and Forecast for Semi-Automatic in the Global Biopsy Gun Market (2019-2035)
  • Figure 5.1: Global Biopsy Gun Market by Application in 2019, 2025, and 2035
  • Figure 5.2: Trends of the Global Biopsy Gun Market ($M) by Application
  • Figure 5.3: Forecast for the Global Biopsy Gun Market ($M) by Application
  • Figure 5.4: Trends and Forecast for Hospitals in the Global Biopsy Gun Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Clinics in the Global Biopsy Gun Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Others in the Global Biopsy Gun Market (2019-2035)
  • Figure 6.1: Trends of the Global Biopsy Gun Market ($M) by Region (2019-2025)
  • Figure 6.2: Forecast for the Global Biopsy Gun Market ($M) by Region (2026-2035)
  • Figure 7.1: Trends and Forecast for the North American Biopsy Gun Market (2019-2035)
  • Figure 7.2: North American Biopsy Gun Market by Type in 2019, 2025, and 2035
  • Figure 7.3: Trends of the North American Biopsy Gun Market ($M) by Type (2019-2025)
  • Figure 7.4: Forecast for the North American Biopsy Gun Market ($M) by Type (2026-2035)
  • Figure 7.5: North American Biopsy Gun Market by Application in 2019, 2025, and 2035
  • Figure 7.6: Trends of the North American Biopsy Gun Market ($M) by Application (2019-2025)
  • Figure 7.7: Forecast for the North American Biopsy Gun Market ($M) by Application (2026-2035)
  • Figure 7.8: Trends and Forecast for the United States Biopsy Gun Market ($M) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican Biopsy Gun Market ($M) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian Biopsy Gun Market ($M) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European Biopsy Gun Market (2019-2035)
  • Figure 8.2: European Biopsy Gun Market by Type in 2019, 2025, and 2035
  • Figure 8.3: Trends of the European Biopsy Gun Market ($M) by Type (2019-2025)
  • Figure 8.4: Forecast for the European Biopsy Gun Market ($M) by Type (2026-2035)
  • Figure 8.5: European Biopsy Gun Market by Application in 2019, 2025, and 2035
  • Figure 8.6: Trends of the European Biopsy Gun Market ($M) by Application (2019-2025)
  • Figure 8.7: Forecast for the European Biopsy Gun Market ($M) by Application (2026-2035)
  • Figure 8.8: Trends and Forecast for the German Biopsy Gun Market ($M) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French Biopsy Gun Market ($M) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish Biopsy Gun Market ($M) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian Biopsy Gun Market ($M) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom Biopsy Gun Market ($M) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC Biopsy Gun Market (2019-2035)
  • Figure 9.2: APAC Biopsy Gun Market by Type in 2019, 2025, and 2035
  • Figure 9.3: Trends of the APAC Biopsy Gun Market ($M) by Type (2019-2025)
  • Figure 9.4: Forecast for the APAC Biopsy Gun Market ($M) by Type (2026-2035)
  • Figure 9.5: APAC Biopsy Gun Market by Application in 2019, 2025, and 2035
  • Figure 9.6: Trends of the APAC Biopsy Gun Market ($M) by Application (2019-2025)
  • Figure 9.7: Forecast for the APAC Biopsy Gun Market ($M) by Application (2026-2035)
  • Figure 9.8: Trends and Forecast for the Japanese Biopsy Gun Market ($M) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian Biopsy Gun Market ($M) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese Biopsy Gun Market ($M) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean Biopsy Gun Market ($M) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian Biopsy Gun Market ($M) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW Biopsy Gun Market (2019-2035)
  • Figure 10.2: ROW Biopsy Gun Market by Type in 2019, 2025, and 2035
  • Figure 10.3: Trends of the ROW Biopsy Gun Market ($M) by Type (2019-2025)
  • Figure 10.4: Forecast for the ROW Biopsy Gun Market ($M) by Type (2026-2035)
  • Figure 10.5: ROW Biopsy Gun Market by Application in 2019, 2025, and 2035
  • Figure 10.6: Trends of the ROW Biopsy Gun Market ($M) by Application (2019-2025)
  • Figure 10.7: Forecast for the ROW Biopsy Gun Market ($M) by Application (2026-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Biopsy Gun Market ($M) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American Biopsy Gun Market ($M) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African Biopsy Gun Market ($M) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Biopsy Gun Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Biopsy Gun Market (2025)
  • Figure 12.1: Growth Opportunities for the Global Biopsy Gun Market by Type
  • Figure 12.2: Growth Opportunities for the Global Biopsy Gun Market by Application
  • Figure 12.3: Growth Opportunities for the Global Biopsy Gun Market by Region
  • Figure 12.4: Emerging Trends in the Global Biopsy Gun Market

List of Tables

  • Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Biopsy Gun Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Biopsy Gun Market by Region
  • Table 1.3: Global Biopsy Gun Market Parameters and Attributes
  • Table 3.1: Trends of the Global Biopsy Gun Market (2019-2025)
  • Table 3.2: Forecast for the Global Biopsy Gun Market (2026-2035)
  • Table 4.1: Attractiveness Analysis for the Global Biopsy Gun Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Biopsy Gun Market (2019-2025)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Biopsy Gun Market (2026-2035)
  • Table 4.4: Trends of Fully Automatic in the Global Biopsy Gun Market (2019-2025)
  • Table 4.5: Forecast for Fully Automatic in the Global Biopsy Gun Market (2026-2035)
  • Table 4.6: Trends of Semi-Automatic in the Global Biopsy Gun Market (2019-2025)
  • Table 4.7: Forecast for Semi-Automatic in the Global Biopsy Gun Market (2026-2035)
  • Table 5.1: Attractiveness Analysis for the Global Biopsy Gun Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Biopsy Gun Market (2019-2025)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Biopsy Gun Market (2026-2035)
  • Table 5.4: Trends of Hospitals in the Global Biopsy Gun Market (2019-2025)
  • Table 5.5: Forecast for Hospitals in the Global Biopsy Gun Market (2026-2035)
  • Table 5.6: Trends of Clinics in the Global Biopsy Gun Market (2019-2025)
  • Table 5.7: Forecast for Clinics in the Global Biopsy Gun Market (2026-2035)
  • Table 5.8: Trends of Others in the Global Biopsy Gun Market (2019-2025)
  • Table 5.9: Forecast for Others in the Global Biopsy Gun Market (2026-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Biopsy Gun Market (2019-2025)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Biopsy Gun Market (2026-2035)
  • Table 7.1: Trends of the North American Biopsy Gun Market (2019-2025)
  • Table 7.2: Forecast for the North American Biopsy Gun Market (2026-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Biopsy Gun Market (2019-2025)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Biopsy Gun Market (2026-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Biopsy Gun Market (2019-2025)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Biopsy Gun Market (2026-2035)
  • Table 7.7: Trends and Forecast for the United States Biopsy Gun Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Biopsy Gun Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Biopsy Gun Market (2019-2035)
  • Table 8.1: Trends of the European Biopsy Gun Market (2019-2025)
  • Table 8.2: Forecast for the European Biopsy Gun Market (2026-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Biopsy Gun Market (2019-2025)
  • Table 8.4: Market Size and CAGR of Various Type in the European Biopsy Gun Market (2026-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Biopsy Gun Market (2019-2025)
  • Table 8.6: Market Size and CAGR of Various Application in the European Biopsy Gun Market (2026-2035)
  • Table 8.7: Trends and Forecast for the German Biopsy Gun Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Biopsy Gun Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Biopsy Gun Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Biopsy Gun Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Biopsy Gun Market (2019-2035)
  • Table 9.1: Trends of the APAC Biopsy Gun Market (2019-2025)
  • Table 9.2: Forecast for the APAC Biopsy Gun Market (2026-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Biopsy Gun Market (2019-2025)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Biopsy Gun Market (2026-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Biopsy Gun Market (2019-2025)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Biopsy Gun Market (2026-2035)
  • Table 9.7: Trends and Forecast for the Japanese Biopsy Gun Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Biopsy Gun Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Biopsy Gun Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Biopsy Gun Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Biopsy Gun Market (2019-2035)
  • Table 10.1: Trends of the ROW Biopsy Gun Market (2019-2025)
  • Table 10.2: Forecast for the ROW Biopsy Gun Market (2026-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Biopsy Gun Market (2019-2025)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Biopsy Gun Market (2026-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Biopsy Gun Market (2019-2025)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Biopsy Gun Market (2026-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Biopsy Gun Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Biopsy Gun Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Biopsy Gun Market (2019-2035)
  • Table 11.1: Product Mapping of Biopsy Gun Suppliers Based on Segments
  • Table 11.2: Operational Integration of Biopsy Gun Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Biopsy Gun Revenue
  • Table 12.1: New Product Launches by Major Biopsy Gun Producers (2019-2025)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Biopsy Gun Market